Alteogen and Tesaro, a subsidiary of GSK, have entered an exclusive license agreement concerning a subcutaneous formulation of dostarlimab.

With star checkpoint inhibitors like Keytruda and Opdivo now sporting subcutaneous formulations, GSK has struck a deal aimed ...

Complex sugar-protein molecules that sense external messages to help a cell grow or respond to its environment can now be ...

The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.

That’s only one problem. Your immune system also has an adaptive system of specialized immune cells and antibodies that attack and destroy invading microbes. This system remembers what those intruders ...

Finally, he has been involved in training generations of extraordinary scientists—the Corey school—who are further shaping ...

Anzen Industries is developing cell-free biomanufacturing technology to produce complex chemicals more efficiently and ...

South Korean food-tech innovator DEEPLANT introduces an AI-powered “Deep-Aging” system using ultrasound to transform ...

A growing body of research suggests that combining enzymes with biochar, a carbon-rich material made from agricultural and ...

Whether they are laundry detergents, mascara, or Christmas chocolate, many everyday products contain fatty acids from palm ...

At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m (1) TP).

Takeda has announced a global collaboration and licence agreement with Halozyme to continue advancing vedolizumab with the ...